The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 1,101–1,200 of 1,644
Haleem, E. N. A. A., & El‐Bakly, W. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.022 · Cited by 14
CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer’s Disease
Posada-Duque, R. A., & Cardona-Gómez, G. P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-200730 · Cited by 14
Davis, C. M., Zhang, W. H., Bah, T. M., Roese, N. E., Allen, E. M., Leung, P., Boutros, S. W., Marzulla, T., Patel, E. M., Nie, X. J., et al. (2022) · npj Aging · doi:10.1038/s41514-022-00090-1 · Cited by 15
Moreno, J., Lanau, A. V., Madrigal, L., Pineda, A. Y. B., Hernandez, J. V., Campo, O., Soto-Ospina, A., Marín, P. A., Rishishwar, L., Norris, E. T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269955 · Cited by 14
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
Moonen, J. E. F., Haan, R., Bos, I., Teunissen, C. E., van de Giessen, E., Tomassen, J., den Braber, A., van der Landen, S. M., de Geus, E. J. C., Legdeur, N., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13607 · Cited by 14
Klugman, A., Marshall, J., & Tabet, N. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02079.x · Cited by 14
Stenset, V. T. V., Hofoss, D., Johnsen, L., Skinningsrud, A., Berstad, A. E., Negaard, A., Reinvang, I., Gjerstad, L., & Fladby, T. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01045.x · Cited by 14
Intracranial large artery disease in Alzheimer’s disease and vascular dementia among ethnic Asians
Silva, D. A. D., Ancalan, M., Doshi, K., Chang, H. M., Wong, M. C. S., & Chen, C. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02551.x · Cited by 14
Weintraub, D. A., & Katz, I. R. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.09.002 · Cited by 14
Convergence of atherosclerosis and Alzheimer's disease
Casserly, I. P., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16473-8 · Cited by 14
Preventing Dementia by Treating Hypertension and Preventing Stroke
Spence, J. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000132374.90924.2a · Cited by 14
Vascular cognitive impairment in dementia
Etherton‐Beer, C. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.06.004 · Cited by 13
Deibel, S. H., Weishaupt, N., Regis, A. M., Hong, N. S., Keeley, R. J., Balog, R. J., Bye, C. M., Himmler, S. M., Whitehead, S. N., & McDonald, R. J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.033 · Cited by 13
Probable Causes of Alzheimer’s Disease
Adams, J. D., Jr. (2021) · Sci · doi:10.3390/sci3010016 · Cited by 12
A double-dichotomy clustering of dual pathology dementia patients
Caprihan, A., Raja, R., Hillmer, L. J., Erhardt, E. B., Prestopnik, J., Thompson, J., Adair, J. C., Knoefel, J. E., & Rosenberg, G. A. (2021) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2021.100011 · Cited by 13
Vascular Contributions to Brain Health: Cross-Cutting Themes
Greenberg, S. M. (2022) · Stroke · doi:10.1161/strokeaha.121.034921 · Cited by 13
Brehaut, J., Raina, P. S., & Lindsay, J. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000080 · Cited by 13
Modeling the Dementia Epidemic
Treves, T. A., & Korczyn, A. D. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00242.x · Cited by 13
Chemical Hypoxia Facilitates Alternative Splicing of EAAT2 in Presymptomatic APP23 Transgenic Mice
Münch, C., Zhu, B., Mink, A., Seefried, U., Riepe, M. W., Ludolph, A. C., & Meyer, T. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9540-5 · Cited by 13
Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease
Chen, S.-G., Gu, R., Dai, H., & Wei, D. (2012) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2012.11.008 · Cited by 13
Engelhardt, E., Tocquer, C., André, C., Moreira, D. M., Okamoto, I. H., & Cavalcanti, J. L. D. S. (2011) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642011dn05040004 · Cited by 13
Yang, Y.-H., Teng, H., Lai, Y., Li, S., Lin, C., Yang, A. C., Chan, H., Hsieh, Y., Lin, C.-F., Hsu, F.-Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137914 · Cited by 13
O'Brien, J. T., & Thomas, A. J. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.15104 · Cited by 14
Koistinaho, M., Kettunen, M. I., Holtzman, D. M., Kauppinen, R. A., Higgins, L. S., & Koıstınaho, J. (2002) · Stroke · doi:10.1161/01.str.0000020124.61998.bc · Cited by 13
Imaging Interactions between Alzheimer's Disease and Cerebrovascular Disease
Wu, C. C., Mungas, D., Eberling, J. L., Reed, B., & Jagust, W. J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04844.x · Cited by 13
Bo, M., Massaia, M., Speme, S., Cappa, G., Strumia, K., Cerrato, P., Ponzio, F., & Molaschi, M. (2005) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2005.06.003 · Cited by 13
Diagnosis, Classification and Natural History of Degenerative Dementias
Feldman, H., & Kertesz, A. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001177 · Cited by 14
Black, S. E., Patterson, C., & Feightner, J. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001219 · Cited by 13
The Convergence of Counseling and Psychiatric Genetics: An Essential Role for Counselors
Douthit, K. Z. (2006) · Journal of Counseling & Development · doi:10.1002/j.1556-6678.2006.tb00376.x · Cited by 13
Factores de riesgo vascular y enfermedad de Alzheimer
Doña, P. J. R., Artigas, P. D. A., Guerra, M. L. S., & Monfort, C. A. (2009) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2008.12.004 · Cited by 15
Lifestyle and Alzheimer’s Disease
Bartolotti, N., & Lazarov, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00007-3 · Cited by 13
A modern concept of mixed dementia
Bogolepova, A. N. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201511551120-126 · Cited by 12
Wang, Q., Su, N., Huang, J., Liang, X., Yuan, J., Yao, M., Zhou, L., Jin, Z., Zhang, S., Cui, L., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210367 · Cited by 12
The Effect of Bacterial Composition Shifts in the Oral Microbiota on Alzheimer's Disease
Moghadam, M. T., Mojtahedi, A., Bakhshayesh, B., Babakhani, S., Ajorloo, P., Shariati, A., Mirzaei, M., Heidarzadeh, S., & Jazi, F. M. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666220819140748 · Cited by 12
Pluta, R. M., Miziak, B., & Czuczwar, S. J. (2023) · Molecules · doi:10.3390/molecules28155624 · Cited by 12
Characterization of Behaviour and Remote Degeneration Following Thalamic Stroke in the Rat
Weishaupt, N., Riccio, P. M., Dobbs, T., Hachinski, V., & Whitehead, S. N. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613921 · Cited by 12
DOERNER, M. F., Beckmann, K., Knappertz, V. A., Kappos, L., Hartung, H., Filippi, M., O'Connor, P. W., Arnason, B. G. W., Cook, S. D., Jeffery, D., et al. (2014) · European Neurology · doi:10.1159/000355530 · Cited by 12
Part III: Principal component analysis: bridging the gap between strain, sex and drug effects
Keeley, R. J., & McDonald, R. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.027 · Cited by 11
Diagnostic Correlates of Alzheimer Dementia in a U.S. Nationwide Inpatient Sample
Preuss, U. W., Watzke, S., & Choi, J. H. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ca3a13 · Cited by 12
Association between cardiovascular disease and dementia
Suemoto, C. K., Ferretti‐Rebustini, R. E. D. L., Grinberg, L. T., de Oliveira, K. C., Farfel, J. M., Leite, R. E. P., Nitríni, R., Filho, W. J., & Pasqualucci, C. A. (2009) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn30400008 · Cited by 12
Evaluating the Patient with Memory Loss or Dementia
Budson, A. E., & Solomon, P. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28661-9.00002-0 · Cited by 12
Menopause, Estrogen, and Gonadotropins in Alzheimer's Disease
Casadesús, G., Rolston, R. K., Webber, K. M., Atwood, C., Bowen, R. L., Perry, G. L., & Smith, M. A. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(07)00006-6 · Cited by 12
Pedelty, L., & Nyenhuis, D. L. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0018-6 · Cited by 12
Nakajo, Y., Yang, D. W., TAKAHASHI, J. C., Zhao, Q., Kataoka, H., & Yanamoto, H. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.042 · Cited by 12
Clinical Aspects of Alzheimer’s Disease
Kurz, A., & Lauter, H. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_70 · Cited by 12
Part I. Epidemiology and public health impact of Alzheimer's disease
Bennett, D. A. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90028-2 · Cited by 12
Clinical Issues in Current Drug Therapy for Dementia
Förstl, H. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00015 · Cited by 12
Is amnestic mild cognitive impairment always AD?
Jagust, W. J. (2008) · Neurology · doi:10.1212/01.wnl.0000299190.17488.b3 · Cited by 12
Namgung, H.-G., Hong, S., & Choi, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124071 · Cited by 11
The Heart and Brain Connection
Vicario, A., & Cerezo, G. H. (2023) · Heart and Mind · doi:10.4103/hm.hm-d-23-00016 · Cited by 11
Godefroy, O., Aarabi, A., Béjot, Y., Biessels, G. J., Glize, B., Mok, V., de Schotten, M. T., Sibon, I., Chabriat, H., & Roussel, M. (2024) · European Stroke Journal · doi:10.1177/23969873241271651 · Cited by 17
Swanson, L. M., Hood, M. M., Thurston, R. C., Butters, M. A., Kline, C. E., Kravitz, H. M., Avis, N. E., Neal-Perry, G. S., Joffe, H., Harlow, S. D., et al. (2025) · SLEEP · doi:10.1093/sleep/zsaf041 · Cited by 10
Heo, C., Lee, S. Y., Jo, A., Jung, S., Suh, M., & Lee, Y. (2013) · ACS Nano · doi:10.1021/nn305884w · Cited by 11
Merino, E. N., Sendín, M. A. C., & Osorio, J. A. V. (2015) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2015.01.002 · Cited by 14
Alzheimer disease neuropathology in the oldest old
Kril, J. J. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.105 · Cited by 11
Pluta, R. M., Januszewski, S., & Czuczwar, S. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126591 · Cited by 10
The Neuropathology of Vascular and Mixed Dementia and Vascular Cognitive Impairment
Hauw, J., Girolami, U. D., & Zekry, D. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01262-6 · Cited by 11
The Management of Hypertension for Primary Stroke Prevention: A Proposed Approach
Sharma, M., & Hakim, A. M. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00569.x · Cited by 11
Relationship between cortical microinfarcts and cognitive impairment in Alzheimer's disease
Damasceno, B. P. (2012) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642012dn06030004 · Cited by 11
First translational ‘Think Tank’ on cerebrovascular disease, cognitive impairment and dementia
Barone, F. C., Gustafson, D., Crystal, H., Moreno, H., Adamski, M. G., Arai, K., Baird, A. E., Balucani, C., Brickman, A. M., Cechetto, D. F., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0806-z · Cited by 11
Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice
Luo, G., Xu, H., Huang, Y., Mo, D., Song, L., Jia, B., Wang, B., Jin, Z., & Miao, Z. (2016) · BioMed Research International · doi:10.1155/2016/8380618 · Cited by 11
Yu, H., Yang, C., Chen, S., Huang, Y., Liu, C., Liu, J., & Yin, W. (2017) · Scientific Reports · doi:10.1038/srep39948 · Cited by 11
Lai, A. Y., Joo, I. L., Trivedi, A. U., Dorr, A. E., Hill, M. E., Stefanovic, B., & McLaurin, J. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147369 · Cited by 12
Ueno, Y., Saito, A., Nakata, J., Kamagata, K., Taniguchi, D., Motoi, Y., Io, H., Andica, C., Shindo, A., Shiina, K., et al. (2021) · Nutrients · doi:10.3390/nu13041292 · Cited by 11
Yokoyama, S., Kajiya, Y., Yoshinaga, T., Tani, A., & Hirano, H. (2014) · Psychogeriatrics · doi:10.1111/psyg.12047 · Cited by 12
Chapter 27 Lacunes and lacunar syndromes
Donnan, G. A., & Norrving, B. G. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)93027-x · Cited by 12
Antecedents of intact cognition and dementia at age 90 years: a prospective study
Vaillant, G. E., Okereke, O. I., Mukamal, K. J., & Waldinger, R. J. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4108 · Cited by 11
Stroke, dementia, and drug delivery
Ford, G. A., Bryant, C. A., Mangoni, A. A., & Jackson, S. H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01939.x · Cited by 11
Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice
Hattori, Y., Maki, T., Saitô, S., Yamamoto, Y., Nagatsuka, K., & Ihara, M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160013 · Cited by 11
Nadkarni, N. K., Tudorascu, D., Campbell, E., Snitz, B. E., Cohen, A. D., Halligan, E., Mathis, C. A., Aizenstein, H. J., & Klunk, W. E. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz088 · Cited by 11
Understanding cognitive impairment and dementia: stroke studies
STARKSTEIN, S. E., & Almeida, O. P. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200311000-00003 · Cited by 11
Chin, A., O'Connell, H. P., Kirby, M., Denihan, A., Bruce, I., Walsh, J. B., Coakley, D., LAWLOR, B. A., & Cunningham, C. J. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1621 · Cited by 11
Tian, Y., Fopiano, K. A., Buncha, V., Lang, L., Suggs, H. A., Wang, R., Rudic, R. D., Filosa, J. A., & Bagi, Z. A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1125932 · Cited by 10
Silbert, L. C. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001508 · Cited by 11
Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
Léger, G. C., & Massoud, F. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.811237 · Cited by 10
Antihypertensives, angiotensin, glucose and Alzheimer’s disease
Nelson, L., Tabet, N., Richardson, C., & Gard, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.32 · Cited by 11
Elman, J. A., Panizzon, M. S., Logue, M. W., Gillespie, N. A., Neale, M. C., Reynolds, C. A., Gustavson, D. E., Rana, B. K., Andreassen, O. A., Dale, A. M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.001 · Cited by 10
Tarkowska, A. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.cerebralischemia.2021.perinatalasphyxia · Cited by 10
Hayden, M. R. (2024) · Biomedicines · doi:10.3390/biomedicines12010096 · Cited by 13
Alzheimer’s therapeutic development: shifting neurodegeneration to neuroregeneration
Sun, M., & Alkon, D. L. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.01.012 · Cited by 11
Mise au point sur les démences vasculaires
Auriacombe, S., Amarenco, P., Baron, J., Ceccaldi, M. P., Dartigues, J., Lehéricy, S., Hénon, H., Hinaut, P., & Orgogozo, J. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2007.06.001 · Cited by 10
Meguro, K., Tanaka, N., Nakatsuka, M., Nakamura, K., & Satoh, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.048 · Cited by 10
Brucki, S. M. D., Machado, M. F., & Rocha, M. S. G. (2012) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642012dn06030009 · Cited by 11
Nižetić, D., Chen, C., Hong, W., & Koo, E. H. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00299 · Cited by 9
Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment
Viswanathan, A., Greenberg, S. M., & Scheltens, P. (2015) · Stroke · doi:10.1161/strokeaha.115.009010 · Cited by 10
Impaired hypoxic tolerance in APP 23 mice: a dysregulation of neuroprotective globin levels
Acker, Z. P. V., Luyckx, E., Leuven, W. V., Geuens, E., Deyn, P. P. D., Dam, D. V., & Dewilde, S. (2017) · FEBS Letters · doi:10.1002/1873-3468.12651 · Cited by 11
Rosenberg, G. A., Prestopnik, J., Knoefel, J. E., Adair, J. C., Thompson, J., Raja, R., & Caprihan, A. (2019) · Brain Sciences · doi:10.3390/brainsci9080187 · Cited by 10
Predicting Cognitive Impairment in Cerebrovascular Disease Using Spoken Discourse Production
Roberts, A., Aveni, K., Basque, S. R., Orange, J. B., McLaughlin, P. M., Ramirez, J., Troyer, A. K., Gutierrez, S., Chen, A., Bartha, R., et al. (2021) · Topics in Language Disorders · doi:10.1097/tld.0000000000000242 · Cited by 10
Wu, M., Schweitzer, N., Iordanova, B. E., Halligan‐Eddy, E., Tudorascu, D., Mathis, C. A., Lopresti, B. J., Kamboh, M. I., Cohen, A. D., Snitz, B. E., et al. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.09.011 · Cited by 10
Is B Vitamins Deficiency Associated with Prevalence of Alzheimer's Disease in Cuban Elderly?
Domínguez, Y. L., Hernández, M., Matos, C. M., & Zhou, D. (2006) · Nutrition and Health · doi:10.1177/026010600601800202 · Cited by 10
Nyenhuis, D. L. (2005) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293705.15841.d6 · Cited by 10
Atherosclerosis Risk Factors in American Indians With Alzheimer Disease
Weiner, M., Rosenberg, R. N., Womack, K. B., Svetlik, D. A., Fuller, C., Fields, J. A., & Hynan, L. S. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318169d701 · Cited by 10
The role of neuroimaging in the diagnosis of vascular dementia
Small, G. W. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.106.s178.3.x · Cited by 10
Tabet, N., Quinn, R., & Klugman, A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01971.x · Cited by 10
The Primary Care of Alzheimer Disease
Rubin, C. D. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200612000-00004 · Cited by 10
Greenman, D., & Bennett, I. J. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.02.004 · Cited by 9
Anwer, M., Poliakova, T., Albanus, R. D., Bhuiyan, M. I. H., Brickman, A. M., Chaudhuri, S., Cuddy, L. K., Eisenbaum, M., Foley, K. E., Gould, D. B., et al. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10210-x · Cited by 8
MacKenzie, J. L., Ivanova, N., Nell, H. J., Giordano, C. R., Terlecky, S. R., Agca, C., Ağca, Y., Walton, P. A., Whitehead, S. N., & Cechetto, D. F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.01.026 · Cited by 9
Mohammadiarvejeh, P., Klinedinst, B. S., Wang, Q., Li, T., Larsen, B. A., Pollpeter, A., Moody, S. N., Willette, S. A., Mochel, J. P., Allenspach, K., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00657-6 · Cited by 12
Nakazawa, T., Ohara, T., Hirabayashi, N., Furuta, Y., Hata, J., Shibata, M., Honda, T., Kitazono, T., Nakao, T., & Ninomiya, T. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13533 · Cited by 9
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
